About the Authors
- Maria Rajecki
-
Contributed equally to this work with: Maria Rajecki, Mirkka Sarparanta
Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
- Mirkka Sarparanta
-
Contributed equally to this work with: Maria Rajecki, Mirkka Sarparanta
Affiliation Laboratory of Radiochemistry, University of Helsinki, Helsinki, Finland
- Tanja Hakkarainen
-
Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
- Mikko Tenhunen
-
Affiliation Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland
- Iulia Diaconu
-
Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
- Venla Kuhmonen
-
Affiliation Laboratory of Radiochemistry, University of Helsinki, Helsinki, Finland
- Kalevi Kairemo
-
Affiliations Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland, International Comprehensive Cancer Center Docrates, Helsinki, Finland
- Anna Kanerva
-
Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland
- Anu J. Airaksinen
-
Affiliation Laboratory of Radiochemistry, University of Helsinki, Helsinki, Finland
- Akseli Hemminki
-
* E-mail: akseli.hemminki@helsinki.fi
Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland
Competing Interests
A. Hemminki is a co-founder and shareholder in Oncos Therapeutics ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.
Author Contributions
Conceived and designed the experiments: MR MS TH MT KK AJA. Performed the experiments: MR MS TH MT KK AJA ID VK. Analyzed the data: MR MS TH MT KK AJA. Wrote the paper: MR MS TH MT AK AJA AH.